CD16a

CD16a 製品リスト

  • 属性

    Antibody (2)Cell (1)

  • 製品ライブラリ

    オンライン (3)

  • Mouse (2)Human (1)

  • タグ

    - (3)

  • マーカー

    PE Labeled (1)APC Labeled (1)- (1)

CD16aバックグランド

CD16 encodes a receptor that recognizes the Fc portion of immunoglobulin G and is involved in the clearance of immune complexes from the circulation, as well as other functions such as cellular mediated cytotoxicity and enhancement of virus infections. This gene, FCGR3A, shares a high degree of similarity with another nearby gene, FCGR3B, located on chromosome 1. The receptor encoded by this gene is expressed on natural killer (NK) cells as an integral membrane glycoprotein anchored through a transmembrane peptide, while FCGR3B is expressed on polymorphonuclear neutrophils (PMN) where the receptor is anchored through a phosphatidylinositol (PI) linkage. Mutations in this gene have been associated with immunodeficiency 20 and have been linked to susceptibility to recurrent viral infections, susceptibility to systemic lupus erythematosus, and alloimmune neonatal neutropenia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Diseases associated with FCGR3A include Immunodeficiency 20 and Herpes Zoster.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
SiplizumabMEDI-507; TCD-601Phase 2 ClinicalCatholic University Of Louvain, Itb-Med LlcMultiple Myeloma; Amyotrophic Lateral Sclerosis; Kidney Failure, Chronic; Plaque psoriasis; Anemia, Sickle Cell; Lymphoma; Lymphoma, T-Cell; Hidradenitis Suppurativa; Hepatitis, Autoimmune; Lymphoma, Extranodal NK-T-Cell; Psoriasis; Cholangitis, Sclerosing; Diabetes Mellitus, Type 1; Liver Diseases; Myelodysplastic Syndromes; Neoplasms; Graft vs Host Disease; Kidney Diseases; Liver Cirrhosis; Renal Insufficiency; Rejection of liver transplantation; Leukemia; End Stage Liver Disease; Rejection of renal transplantation
詳細
AlefaceptLFA-3-TIP; LFA-3(92)IgG; BG-9273; BG-9712; ASP-0485Phase 1 ClinicalAstellas Pharma IncDiabetes Mellitus, Type 1; Graft vs Host Disease; Psoriasis; Anemia, Aplastic; Lymphoma
詳細
SBT-11-5301SBT115301Phase 1 ClinicalSonoma Biotherapeutics IncAutoimmune Diseases
詳細
PIT-565PIT-565Phase 1 ClinicalNovartis Pharma AgLymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lupus Erythematosus, Systemic; Leukemia, Myeloid, Acute
詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8